Your trusted destination for CME, CPD & Medical Education across the Middle East.
University of Dundee / NHS Tayside, Scotland, United Kingdom
Prof. Christopher Barratt is a internationally recognized authority in andrology, reproductive medicine, and male fertility. He earned his PhD in Zoology from the University of Birmingham and was later awarded a Doctor of Science (DSc) from the same institution for his ground-breaking contributions to reproductive biology. He is a Fellow of the Royal Society of Edinburgh (FRSE).
Prof. Barratt serves as Head of the Reproductive Medicine Group at the University of Dundee and holds a clinical appointment with NHS Tayside. His career spans several major leadership positions, including Scientific Director of the ART Centre at Birmingham Women's Hospital and Co-Editor-in-Chief of Human Reproduction. He has been instrumental in shaping global standards in male reproductive health, serving on the World Health Organization (WHO) Male Fertility Semen Analysis Taskforce and directing the WHO Male Fertility Expert Working Group.
With over 300 peer-reviewed scientific publications and an hh-index over 60, Prof. Barratt's research focuses on sperm motility, ion channel signaling (such as CatSper), phenotypic high-throughput screening for male contraceptives, and the genetic underpinnings of male infertility. He actively leads international initiatives to elevate male reproductive health to the forefront of ART clinical care.
As a keynote speaker at the 2nd Trust Fertility & Gynecology Conference 2026, Prof. Barratt brings global expertise to discussions on male-factor infertility. His presentations focus on diagnostic innovations, optimizing male fertility potential prior to ART, and translating basic sperm biology into actionable clinical strategies to improve IVF outcomes.
